Skip to content
Open access

ACSL4 Modulates Ferroptosis-Associated Injury and Mitochondrial Dysfunction in MC3T3-E1 Cells

2026 · Biocell (Mendoza) · 0 citations · 52 references

Abstract

: Objective: Iron overload may impair bone-forming cells partly through ferroptosis-associated lipid peroxidation. This study examined the role of acyl-CoA synthetase long-chain family member 4 (ACSL4) in ferroptosis-associated injury and mitochondrial dysfunction in ferric ammonium citrate (FAC)-treated MC3T3-E1 osteoblast-like cells. It assessed the functional involvement of estrogen-related receptor alpha (ERR α ) and SRY-box transcription factor 9 (SOX9). Methods: We established an in vitro iron-overload model by exposing MC3T3-E1 osteoblast-like cells to ferric ammonium citrate (FAC). Cell viability, malondialdehyde (MDA), 4-hydroxynonenal (4-HNE), intracellular Fe 2+ , mitochondrial membrane potential, mitochondrial reactive oxygen species (mtROS), and ATP content were assessed. ACSL4 was knocked down or overexpressed, and ERR α or SOX9 was knocked down in the ACSL4-silenced background. Results: Relative to control, FAC reduced cell viability by approximately 54%, increased MDA and 4-HNE by about 3.0-fold and intracellular Fe 2+ by about 2.1-fold, increased mtROS by about 6.2-fold, and reduced mitochondrial membrane potential and ATP content by approximately 58% and 50%, respectively (all p < 0.05). Ferrostatin-1 attenuated these changes, whereas erastin exacerbated them. ACSL4 knockdown mitigated, and ACSL4 overexpression aggravated, the FAC-associated changes. Both ERR α and SOX9 mRNA and protein abundance changed inversely with ACSL4 expression; knockdown of either factor attenuated the protective phenotype associated with ACSL4 silencing. Conclusion: In FAC-treated MC3T3-E1 cells, ACSL4 contributes to a ferroptosis-associated injury phenotype and mitochondrial dysfunction, with functional involvement of ERR α and SOX9. The direct molecular relationships and relevance to osteoporosis in vivo remain to be established.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.